High-concentration tramadol-induced vasodilation in rabbit aorta is mediated by both endothelium-dependent and -independent mechanisms

Acta Pharmacologica Sinica

Volumn 24, Issue 5, 2003, Pages 385-389+477

  Kaya, Tijen ^a   Gursoy, Sinan ^a   Karadas, Baris ^a   Sarac, Bulent ^a   Kafali, Haluk ^a   Soydan, Ahmet Serdar ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

Endothelium; Thoracic aorta; Tramadol; Vasodilation

Indexed keywords

GLIBENCLAMIDE; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NALOXONE; PHENYLEPHRINE; TETRYLAMMONIUM CHLORIDE; TRAMADOL;

ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; ENDOTHELIUM; MUSCLE ISOMETRIC CONTRACTION; MUSCLE RELAXATION; NONHUMAN; SMOOTH MUSCLE CONTRACTION; THORACIC AORTA; VASCULAR RING; VASODILATATION;

ANALGESICS, OPIOID; ANIMALS; AORTA, THORACIC; ENDOTHELIUM, VASCULAR; NG-NITROARGININE METHYL ESTER; RABBITS; TRAMADOL; VASODILATION;

EID: 0037693991     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Desmeules J, Piguet V, Collart L, Dayer P. Yohimbine antagonism as a tool to assess extent of monoaminergic modulation in analgesic effect: experience with tramadol. Experientia 1994: 50; 79.
2. Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL. Opioid and non-opioid components independently contribute to the mechanism of action of tramadol, an atypical opioid analgesic. J Pharm Exp Ther 1992: 260; 275-85.
3. Collart L, Lutty C, Dayer P. Partial inhibition of tramadol antinoniceptive effect by naloxone in man. Br J Clin Pharmacol 1993: 35; 73.
4. Vickers MD, O'Flaherty D, Szekely SM, Read M, Yoshizumi J. Tramadol: pain relief by an opioid without depression of respiration. Anaesthesia 1992: 47; 291-6.
5. Hennies HH, Friderichs E, Schneider J. Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids. Arzneimittelforschung 1988: 38; 877-80.
6. Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL, et al. Complemantary and synergistic antinoniceptive interaction between the enantiomers of tramadol. J Pharm Exp Ther 1993: 267; 331-40.
7. Ellmauer S, Dick W, Otto S, Muller H. Verschiedene Opioide beim kardiovaskul und auml; ren Risikopatienten. Anaesthesist 1994: 43; 743-9.
8. Tryba M, Zenz M. Wirksamkeit und Nebenwirkungen von Opioiden und alpha-Adrenorezeptoragonisten inder Therapie postoperativer Schmerzen. Schmerz 1992: 6; 182-91.
9. Karsch K, Wiegand V, Blandke H, Kreuzer H. Wirkung eines neuen Analgetikums (Tramadol) auf die Hauml; modynamik bei Patienten mit koronarer Herzkrankheit. Z Kardiol 1979: 68; 599-603.
10. Retting G, Kropp J. Analgetische Wirkung von tramadol beim akuten Myocardinfarkt. Therapiewocche 1980: 30; 5561-6.
11. Osterloh G, Friderichs E, Felgenhauer F, Gunzler WA, Henmi Z, Kitano T, et al. General pharmacological studies on tramadol, a potent analgetic agent. Arzneimittelforschung 1978: 28; 135-51.
12. Rapoport R, Murad F. Agonist-induced endothelium dependent relaxation in rat thoracic aorta may be mediated through cGMP. Circ Res 1983: 52; 352-7.
13. Johns RA. Endothelium-derived relaxing factors: basic review and clinical implications. J Cardiothorac Anesth 1991: 5; 69-79.
14. Van Houtte PM. Endothelium and control of vascular function. Hypertension 1989: 13; 658-67.
15. Myers PR, Minor RL, Guerra R, Bates JN, Harrison DG. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide. Nature 1990: 10; 161-3.